You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 65862-0883


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 65862-0883

Drug NameNDCPrice/Unit ($)UnitDate
MINOCYCLINE ER 55 MG TABLET 65862-0883-30 2.69758 EACH 2025-04-23
MINOCYCLINE ER 55 MG TABLET 65862-0883-30 2.75622 EACH 2025-03-19
MINOCYCLINE ER 55 MG TABLET 65862-0883-30 2.86948 EACH 2025-02-19
MINOCYCLINE ER 55 MG TABLET 65862-0883-30 2.93584 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 65862-0883

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Drug NDC: 65862-0883

Introduction to Drug NDC: 65862-0883

The National Drug Code (NDC) 65862-0883 is associated with a specific pharmaceutical product manufactured by Aurobindo Pharma Limited. To conduct a comprehensive market analysis and make price projections, it is crucial to understand the drug's characteristics, market dynamics, and historical pricing trends.

Drug Characteristics

Drug Identification

The NDC 65862-0883 corresponds to a specific drug product, but the exact trade name and active ingredients are not provided in the sources. However, Aurobindo Pharma Limited is known for manufacturing a wide range of generic and specialty pharmaceuticals, including antiretrovirals, antibiotics, and cardiovascular medications[1].

Therapeutic Class

Understanding the therapeutic class of the drug is essential for analyzing its market. Drugs from Aurobindo Pharma Limited span various therapeutic classes, including cardiovascular, respiratory, and infectious diseases[1].

Market Dynamics

Competition and Market Structure

The pharmaceutical market is highly competitive, especially for generic drugs. The presence of multiple source drugs (generics) can significantly impact pricing. For instance, multi-source drugs tend to have higher percentage price increases compared to single-source drugs, although the absolute dollar increases are typically lower for multi-source drugs[2].

Regulatory Environment

Regulatory changes and policies can significantly influence drug prices. For example, the Medicare Drug Price Negotiation Program, set to begin in 2026, aims to negotiate lower prices for certain drugs, which could impact the broader market[4].

Historical Pricing Trends

Price Increases and Inflation

From January 2022 to January 2023, the average price increase for prescription drugs was 15.2%, with multi-source drugs experiencing higher percentage increases (26.0%) compared to single-source drugs (7.4%)[2].

Specific Examples

Some drugs have seen extraordinary price increases. For example, Vasopressin had a 3,558% price increase from January 2022 to January 2023, while other drugs like Zolgensma, used to treat spinal muscular atrophy, saw significant dollar value increases ($63,750)[2].

Factors Influencing Price

Patent Protection and Market Exclusivity

Patent protection and market exclusivity can limit competition, allowing drug companies to maintain higher prices to recoup research and development costs[3].

Corporate Consolidations and Supply Chain Disruptions

Corporate consolidations and supply chain disruptions can also contribute to price increases. For instance, the transfer of drug rights and production disruptions can reduce competition and increase prices[3].

Price Projections for NDC: 65862-0883

Short-Term Projections

Given the historical trend of average price increases around 15.2% for prescription drugs, it is reasonable to project a similar or slightly higher increase for the drug associated with NDC 65862-0883 in the short term, assuming it follows the market average.

Long-Term Projections

In the long term, the impact of regulatory changes, such as the Medicare Drug Price Negotiation Program, could lead to more stable or reduced prices for certain drugs. However, without specific details on the drug's therapeutic class and market position, it is challenging to make precise long-term projections.

Scenario Analysis

  • Best Case: If the drug faces increased competition or is subject to negotiated prices under new regulatory frameworks, prices might stabilize or decrease.
  • Worst Case: If the drug maintains market exclusivity or faces supply chain disruptions, prices could increase significantly.
  • Most Likely Case: A moderate increase in line with historical averages, considering the drug's position in a competitive market.

Key Takeaways

  • Market Competition: The presence of multiple source drugs can influence pricing dynamics.
  • Regulatory Impact: Upcoming regulatory changes could affect drug prices significantly.
  • Historical Trends: Recent price increases have been substantial, with an average of 15.2% from January 2022 to January 2023.
  • Projections: Short-term projections suggest a moderate increase, while long-term projections are uncertain due to regulatory and market factors.

FAQs

What is the significance of NDC codes in pharmaceuticals?

NDC codes are unique identifiers for pharmaceutical products, helping in tracking, inventory management, and regulatory compliance.

How do regulatory changes impact drug prices?

Regulatory changes, such as the Medicare Drug Price Negotiation Program, can lead to negotiated lower prices, affecting the overall market pricing dynamics.

What factors contribute to extraordinary price increases in prescription drugs?

Factors include patent protection, market exclusivity, corporate consolidations, and supply chain disruptions.

How does competition affect drug pricing?

Increased competition, especially from generic drugs, can lead to lower prices, while limited competition can result in higher prices.

What is the role of historical pricing trends in making future price projections?

Historical pricing trends provide a baseline for understanding average price increases and can help in making informed projections, though they must be adjusted for current market and regulatory conditions.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.